| scholarly article | Q13442814 |
| P50 | author | Richard Flavell | Q2149481 |
| Till Strowig | Q51326231 | ||
| Ellice Wong | Q114736416 | ||
| P2093 | author name string | Lin Zhang | |
| David G Schatz | |||
| Kavita M Dhodapkar | |||
| Madhav V Dhodapkar | |||
| Srinivas Koduru | |||
| Matthew P Strout | |||
| Ranjini Sundaram | |||
| P2860 | cites work | Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme | Q29547201 |
| Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. | Q30490975 | ||
| A coming-of-age story: activation-induced cytidine deaminase turns 10. | Q33605445 | ||
| Origin of chromosomal translocations in lymphoid cancer | Q33870612 | ||
| Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination | Q34095055 | ||
| Multiple myeloma: evolving genetic events and host interactions | Q34624999 | ||
| Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells | Q35102323 | ||
| Controversies in clinical cancer dormancy | Q35134139 | ||
| Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. | Q35148879 | ||
| Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? | Q35584599 | ||
| CD28-mediated regulation of multiple myeloma cell proliferation and survival | Q35828826 | ||
| Enhancement of clonogenicity of human multiple myeloma by dendritic cells | Q36082990 | ||
| Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. | Q36146840 | ||
| Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy | Q36371527 | ||
| In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. | Q36375533 | ||
| MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma | Q36446189 | ||
| AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development | Q36853393 | ||
| Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma | Q36915925 | ||
| The malignant clone and the bone-marrow environment | Q37028547 | ||
| Estrogen directly activates AID transcription and function | Q37061875 | ||
| RANK/RANKL: regulators of immune responses and bone physiology | Q37348448 | ||
| Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease | Q37396070 | ||
| Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes | Q37419452 | ||
| gammaH2AX: a sensitive molecular marker of DNA damage and repair | Q37687078 | ||
| Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity | Q37704005 | ||
| Impaired NHEJ function in multiple myeloma | Q39913010 | ||
| Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: therapeutic implications | Q40183444 | ||
| Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients | Q42742001 | ||
| A Cyclooxygenase-2/Prostaglandin E2 Pathway Augments Activation-Induced Cytosine Deaminase Expression within Replicating Human B Cells | Q42870169 | ||
| AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. | Q43059808 | ||
| High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease | Q43127229 | ||
| Expression of the AID protein in normal and neoplastic B cells | Q45013739 | ||
| AID is required for c-myc/IgH chromosome translocations in vivo | Q45021537 | ||
| Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma | Q45037008 | ||
| Two levels of protection for the B cell genome during somatic hypermutation. | Q46755254 | ||
| Induction of the unfolded protein response after monocyte to macrophage differentiation augments cell survival in early atherosclerotic lesions. | Q53294172 | ||
| Detection of Kaposi's sarcoma herpesvirus DNA sequences in multiple myeloma bone marrow stromal cells | Q53936841 | ||
| Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro | Q54373221 | ||
| Osteoprotegerin expression in dendritic cells increases with maturation and is NF-kappaB-dependent | Q79435466 | ||
| A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus | Q79746229 | ||
| The relative spatial distribution of CFU-S in the mouse spleen | Q93631820 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 2302-2309 | |
| P577 | publication date | 2012-01-10 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma | |
| P478 | volume | 119 |
| Q64231693 | A 30-Year-Old Carrier of Gaucher Disease with Multiple Myeloma |
| Q41091865 | A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival. |
| Q37068312 | Cancer as an immune-mediated disease |
| Q36719221 | Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma |
| Q64061199 | Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells |
| Q36097337 | Exome sequencing of a colorectal cancer family reveals shared mutation pattern and predisposition circuitry along tumor pathways |
| Q38932298 | Extracellular matrix and the myeloid-in-myeloma compartment: balancing tolerogenic and immunogenic inflammation in the myeloma niche |
| Q38115576 | Genomic instability in multiple myeloma: mechanisms and therapeutic implications |
| Q64257450 | Germline Risk Contribution to Genomic Instability in Multiple Myeloma |
| Q26796307 | Immune Modulation in Hematologic Malignancies |
| Q41971408 | Lysosomal Storage Disorders and Malignancy |
| Q38979865 | MGUS to myeloma: a mysterious gammopathy of underexplored significance |
| Q38188051 | Mechanisms of oncogenic chromosomal translocations |
| Q47702288 | MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells |
| Q37402009 | Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice. |
| Q35175289 | NOD/SCID-GAMMA mice are an ideal strain to assess the efficacy of therapeutic agents used in the treatment of myeloma bone disease |
| Q38702294 | Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response |
| Q40843669 | PREVENTING THE CHROMOSOMAL TRANSLOCATIONS THAT CAUSE CANCER |
| Q91844697 | Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting |
| Q91644110 | Wwox Deletion in Mouse B Cells Leads to Genomic Instability, Neoplastic Transformation, and Monoclonal Gammopathies |
Search more.